Selinexor
Selinexor Receives Fast Track Designation from FDA for Myelofibrosis Treatment
SG Tylor
Source – Karyopharm Therapeutics The FDA has granted fast track designation to selinexor (Xpovio) for the treatment of patients with ...
SELINEXOR AND RUXOLITINIB’S PHASE III TRIAL IN JAKI-NAIVE MYELOFIBROSIS BEGINS
SG Tylor
Source – Karyopharm Therapeutics Karyopharm Therapeutics has initiated a Phase III clinical trial (NCT04562389) to evaluate the effectiveness and safety ...
